Delivery Order SPE2DB22D2206-SPE2DB25FGT47

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,605.44 firm-fixed-price contract is for the supply of 250 mg vials of the drug Ryanodex, with a completion date of July 2, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 250 mg vials of the medication Ryanodex. The contract has a ceiling value of $2,979.28 and a period of performance through August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $4,468.92 and a period of performance through September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by defense and civilian agencies to provide a wide range of essential...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 250 mg vials of the pharmaceutical product Ryanodex. The award is valued at $4,623.36 and has an ultimate completion date of January 13, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,979.28 firm fixed price delivery order is for the supply of Ryanodex 250 mg vials, a specialty pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ryanodex 250 mg vials. The delivery order, valued at $4,468.92, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the U.S. Department of Defense, delivering a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 250 mg Ryanodex vials. The contract has a ceiling value of $4,468.92 and an ultimate completion date of August 14, 2024. It is a delivery order contract with a firm fixed-price pricing type. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $4,468.92 and a completion date of August 19, 2024. AmerisourceBergen, a for-profit organization, is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential medical commodities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGT47
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ryanodex 250 mg vials, a medication used for the treatment of malignant hyperthermia. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.44 and a performance period ending on May 19, 2025.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

The contract does not have a set-aside designation, indicating that it was awarded through open competition.

Generated 7/28/25, 11:05 AM